Latest News May 26, 2026 Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026 May 14, 2026 Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) View All News Latest Quarterly Earnings Results Corporate Presentation ESPR Company Presentation - March 2026 6.6 MB Investor Events Upcoming Events More events are coming soon. Past Events May 28, 2026 8:00 AM EDT Esperion Therapeutics, Inc. 2026 Annual Meeting of Stockholders Apr 13, 2026 9:30 AM EDT 25th Annual Needham Virtual Healthcare Conference View All Events
May 26, 2026 Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026